staging.microbiomepost.com Open in urlscan Pro
89.46.227.163  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to content
LEARN MORE
ADD YOUR COMPANY


LEARN MORE
ADD YOUR COMPANY


 * Companies
 * News
 * Events
 * Production Steps
 * Functions

 * Companies
 * News
 * Events
 * Production Steps
 * Functions

 * Companies
 * News
 * Events
 * Production Steps
 * Functions

 * Companies
 * News
 * Events
 * Production Steps
 * Functions

Welcome to the global microbiome space
Select production steps type something
Production stepsProbiotics, LBPs, prebiotics & postbioticsQuality
assurancePreclinical & Clinical TrialsProduction & ManufacturingGo-to-market
Production steps
No results found
Probiotics, LBPs, prebiotics & postbiotics (15)
Quality assurance (5)
Preclinical & Clinical Trials (8)
Production & Manufacturing (15)
Go-to-market (11)

Submit

MENDES SA

Probiotics, LBPs, prebiotics & postbiotics

LACTOSAN INTERNATIONAL GMBH & CO KG

Production & Manufacturing

VERMICON AG

Quality assurance + Preclinical & Clinical Trials

TARGEDYS

Probiotics, LBPs, prebiotics & postbiotics + Go-to-market
Explore all companies
Read the latest news
Keep up-to-date with the latest business & market news
EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis
treatment
12 November, 2024
October 2024 review: M&A, licensing, and investments in one place
6 November, 2024
Codex Committee on Nutrition and Foods for Special Dietary Uses Concludes 44th
Session without Adopting Probiotic Guidelines
30 October, 2024
The gut, conductor of our health. The International Yakult Symposium congress
report  
15 October, 2024
Health Canada Authorizes Functional Claim for SynbÆctive® Femme, a Patented
Probiotic Formula for Women’s Health
24 September, 2024
European microbiome leaders unite to accelerate global therapeutic development
23 September, 2024
MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the
stage for future advances
26 November, 2024
Freya Biosciences secures $10.4 million investment to tackle women’s health
challenges
20 November, 2024
From Biofarma Group a probiotic therapy as an adjuvant to cancer immunotherapy
19 November, 2024
QIAGEN and McGill University partner to drive innovation in microbiome research
14 November, 2024
EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis
treatment
12 November, 2024
October 2024 review: M&A, licensing, and investments in one place
6 November, 2024
Codex Committee on Nutrition and Foods for Special Dietary Uses Concludes 44th
Session without Adopting Probiotic Guidelines
30 October, 2024
The gut, conductor of our health. The International Yakult Symposium congress
report  
15 October, 2024
Health Canada Authorizes Functional Claim for SynbÆctive® Femme, a Patented
Probiotic Formula for Women’s Health
24 September, 2024
European microbiome leaders unite to accelerate global therapeutic development
23 September, 2024
MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the
stage for future advances
26 November, 2024
Freya Biosciences secures $10.4 million investment to tackle women’s health
challenges
20 November, 2024
From Biofarma Group a probiotic therapy as an adjuvant to cancer immunotherapy
19 November, 2024
QIAGEN and McGill University partner to drive innovation in microbiome research
14 November, 2024
EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis
treatment
12 November, 2024
October 2024 review: M&A, licensing, and investments in one place
6 November, 2024
Codex Committee on Nutrition and Foods for Special Dietary Uses Concludes 44th
Session without Adopting Probiotic Guidelines
30 October, 2024
The gut, conductor of our health. The International Yakult Symposium congress
report  
15 October, 2024
Health Canada Authorizes Functional Claim for SynbÆctive® Femme, a Patented
Probiotic Formula for Women’s Health
24 September, 2024
European microbiome leaders unite to accelerate global therapeutic development
23 September, 2024
Read more
Calendar
Don't miss the upcoming scientific events

10TH CONGRESS OF THE INTERNATIONAL HUMAN MICROBIOME CONSORTIUM (IHMC)

22/06/2024 25/06/2024 Rome, Italy Learn More

PROBIOTA GLOBAL 2024

07/02/2024 09/02/2024 Milan, Italy Learn More

THE FUTURE OF THE MICROBIOME WINTER SUMMIT 2023

14/11/2023 16/11/2023 Virtual Conference Learn More

MICROBIOME DATA CONGRESS – MDC 2023

13/11/2023 14/11/2023 Boston, MA Learn More

MICROBIOME MOVEMENT – HUMAN NUTRITION

07/11/2023 09/11/2023 Livingston, NJ Learn More

SUPPLY SIDE WEST 2023

23/10/2023 27/10/2023 Mandalay Bay, Las Vegas, NV Learn More

Register or Login and take full advantage of MicrobiomeHub‘s features.

Access the user dashboard
See all

PROBIOTICS, LBPS, PREBIOTICS & POSTBIOTICS

When thinking about microbiome based products, nowadays one should consider not
only probiotics, but also prebiotics (together synbiotics) and postbiotics as
well, which have been in the spotlight lately. In any case, it must be verified
that the production facility is fully compliant and, above all, that it
guarantees the highest standards in terms of production, yield and stability.
See companies




QUALITY ASSURANCE

Quality is a “must”. Probiotics should be strictly controlled and tested along
the entire production chain, in order to always be safe from an industrial point
of view and from the consumer perspective. QA practice has to be carried out
from professionals trained and skilled when referred to probiotics.
See companies




PRECLINICAL & CLINICAL TRIALS

Every time a probiotic strain or a finished product refers to a health claim, it
has to be substantiated with a clinical study. Depending on local legislations
in the different areas, clinical studies are mandatory to support a specific
claim/s on finished products to be commercialized.
See companies




PRODUCTION & MANUFACTURING

R&D and Innovation teams are the guardian of the “chain of life” of a probiotic
strain. Similarly, the contract manufacturing requires equipment and skills to
preserve, implement and maintain along the shelf life of the product the
properties and beneficial characteristics. The very last step of the entire
chain is packaging and labelling, which can affect both the shelf life of the
finished product and the compliance into the market.
See companies




GO-TO-MARKET

You have fulfilled all the above steps; you have the perfect product and you
want to conquer more share out into the market? The global market is huge and in
continuous growth, with many opportunities till not fully exploited. Sound
science, together with Quality, Innovation are the elements that will allow you
to find your place.
See companies



Browse companies by functions
TestingAdvertisingAnalysisBlendingCertificationsClinical TrialsCultures &
StartersEducationalFermentationFormulationFreeze
DryingIdentificationMarketingMillingPostbioticsProbiotic
StrainsProductionRegulatorySoftwareTableting
Explore all companies

MicrobiomeHUB is a space that brings together the companies of the microbiome
industry

Brought to you by Clorofilla Scientific Publishing

Facebook-f Linkedin Youtube

This communication is only intended for business-to-business and health care
professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

© 2016-2024 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomeHUB’s Privacy Policy

Scroll to Top


X

microbiomepost.com

We believe your data is your property and support your right to privacy and
transparency.
Select a Data Access Level and Duration to choose how we use and share your
data.
Reject AllAccept SomeAccept All
1 month6 months12 months

Highest level of privacy. Data accessed for necessary basic operations only.
Data shared with 3rd parties to ensure the site is secure and works on your
device

Balanced experience. Data accessed for content personalisation and site
optimisation. Data shared with 3rd parties may be used to track you and store
your preferences for this site.

Highest level of personalisation. Data accessed to make ads and media more
relevant. Data shared with 3rd parties may be use to track you on this site and
other sites you visit.

Consent Preferences
Use the toggles below to specify your data sharing purposes for this website.
Basic Operations
This type of sharing is necessary for us to access the data we need to make sure
the website is secure and working properly.
Data Accessed:
 * Anonymous data like browser name and version
 * Pseudonymous data like authentication token

Content Personalization
When enabled, you allow us to save your preferences and create a profile about
you so we can deliver personalized content.
Data Accessed:
 * Anonymous data like device type, model and operating system
 * Pseudonymous data like site browsing preferences
 * Personal data like your IP address and location

Site Optimization
When enabled, you allow us to monitor your behavior so we can analyze and
improve the services on our website for all visitors.
Data Accessed:
 * Anonymous data like the address of the previously visited website (HTTP
   Referer)
 * Pseudonymous data like website activity identifiers
 * Personal data like content, search and purchase history

Ad Personalization
When enabled, you allow us access to share data with our advertising partners
that build profiles about you across multiple websites.
Data Accessed:
 * Anonymous data like affiliate referral links
 * Pseudonymous data like identifiers used to track and profile users
 * Personal data like your age, gender and demographics

Protection & Metrics
View your consent record, and the list of 3rd parties blocked and allowed based
on your settings.
Consent Metrics

Consent ID—Date of Consent—Data Access Level—Purpose Categories—Duration of
Consent—

Privacy Protection
Services Blocked
 * —

Services Allowed
 * Google Fonts
 * Matomo

Save my preferences
 * Customize

 * Privacy policy